|
SNX1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.43499999993857E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.14469999934875E-09 |
| Normal-vs-Stage2 |
4.701700E-02 |
| Normal-vs-Stage3 |
7.625800E-02 |
| Normal-vs-Stage4 |
8.234000E-04 |
| Stage1-vs-Stage2 |
1.669650E-01 |
| Stage1-vs-Stage3 |
1.535650E-01 |
| Stage1-vs-Stage4 |
3.476200E-01 |
| Stage2-vs-Stage3 |
9.503400E-01 |
| Stage2-vs-Stage4 |
3.935800E-02 |
| Stage3-vs-Stage4 |
1.151800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.36870000070289E-08 |
| Normal-vs-AfricanAmerican |
4.044300E-03 |
| Normal-vs-Asian |
5.381400E-01 |
| Caucasian-vs-AfricanAmerican |
3.849000E-01 |
| Caucasian-vs-Asian |
8.346000E-01 |
| AfricanAmerican-vs-Asian |
9.658400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.57839996207355E-09 |
| Normal-vs-Female |
3.239800E-02 |
| Male-vs-Female |
2.288100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.156490E-03 |
| Normal-vs-Extreme_Weight |
1.27260000315488E-08 |
| Normal-vs-Obese |
1.556840E-03 |
| Normal-vs-Extreme_Obese |
3.357800E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.086400E-01 |
| Normal_Weight-vs-Obese |
5.177800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.687800E-01 |
| Extreme_Weight-vs-Obese |
1.341410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.932600E-01 |
| Obese-vs-Extreme_Obese |
5.597600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.705760E-01 |
| Normal-vs-Age(41-60Yrs) |
1.027450E-04 |
| Normal-vs-Age(61-80Yrs) |
1.70319999992508E-07 |
| Normal-vs-Age(81-100Yrs) |
1.195510E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.435600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.712400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.156800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.767200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.068600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.093400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.42499999969503E-07 |
| Normal-VS-Type2 PRCC |
1.738030E-03 |
| Normal-VS-KIRP CIMP |
2.321600E-03 |
| Normal-VS-Unclassified PRCC |
6.399800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.790800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.471200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.690800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.328000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.927000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.242610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.551800E-04 |
| Normal-vs-N1 |
1.015940E-02 |
| Normal-vs-N2 |
8.591900E-04 |
| N0-vs-N1 |
9.042800E-01 |
| N0-vs-N2 |
5.311800E-01 |
| N1-vs-N2 |
5.889000E-01 |
|
|
